Somatic mutations in ASXL1, TET2 and SRSF2 are generally common in MDS/MPN, including MDS/MPN-U and, like CMML, having mutations in multiple genes is associated with an adverse prognosis [40, 41]. Here, TET2 is linked to myeloproliferative disorder.